A systematic review and meta-analysis of HCV clearance

Liver Int. 2017 Oct;37(10):1431-1445. doi: 10.1111/liv.13401. Epub 2017 Mar 30.

Abstract

While hepatitis C exemplifies the role of host genetics in infectious diseases outcomes, there is no comprehensive overview of polymorphisms influencing spontaneous and/or treatment-induced hepatitis C virus clearance. We performed a systematic review and meta-analysis of host polymorphisms associated with these phenotypes. Literature search was conducted using combinations of keywords in three databases. Studies were reviewed and relevant data systematically extracted for subsequent meta-analyses. Polymorphisms from candidate gene studies were tested in two cohorts of HCV-infected patients with available genomic data. The literature search yielded 8'294 citations, among which 262 studies were selected. In the meta-analysis of 27 HLA studies, the most significant associations with spontaneous hepatitis C virus clearance included DQB1*02, DQB1*03, DRB1*04 and DRB1*11. In the meta-analysis of 16 studies of KIR genes and their HLA-ligands, KIR2DS3 was associated with both spontaneous and treatment-induced clearance, and the HLA-C2 ligand with failure to spontaneously clear the virus. In a pooled analysis of 105 candidate genes and two genome-wide association studies, we observed associations of single nucleotide polymorphisms from nine genes (EIF2AK2, IFNAR2, ITPA, MBL2, MX1, OASL, SPP1, TGFB1, TNK2) with response to interferon-based therapy. Meta-analysis of 141 studies confirmed the association of IFNL3/4 polymorphisms with spontaneous and treatment-induced hepatitis C virus clearance, even in previously underpowered groups, such as hepatitis C virus genotypes 2/3-infected patients. This study may contribute to a better understanding of hepatitis C virus immunopathogenesis and highlights the complex role of host genetics in hepatitis C virus clearance.

Keywords: hepatitis C; host genetics; spontaneous clearance; sustained virological response.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Genotype
  • HLA Antigens / genetics*
  • Hepacivirus / drug effects
  • Hepacivirus / genetics
  • Hepacivirus / pathogenicity*
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy
  • Hepatitis C / genetics*
  • Hepatitis C / virology*
  • Host-Pathogen Interactions
  • Humans
  • Odds Ratio
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Receptors, KIR / genetics*
  • Sustained Virologic Response
  • Treatment Outcome

Substances

  • Antiviral Agents
  • HLA Antigens
  • Receptors, KIR